Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Clinical Evaluation of the Access Socket Flexible Socket for Transtibial Prosthesis (AS-TT)

Transtibial amputation significantly impacts patient autonomy and quality of life, primarily due to the limitations of conventional rigid sockets, which restrict comfort and joint range of motion. The Access Socket (AS) is an innovative prosthetic socket combining a rigid carbon-fiber structure in key load-bearing areas with flexible urethane-resin (ProtheFLEX®) zones in regions typically rigid in conventional sockets. This hybrid design aims to improve comfort and pressure distribution while preserving the mechanical properties required for ambulation.

The AS has already demonstrated benefits in transfemoral amputees and is now reimbursed in France for that population. A preliminary uncontrolled study in 12 transtibial amputees suggested significant improvements in perceived function, comfort, satisfaction, and mobility.

This multicenter, randomized, open-label, two-arm crossover study aims to compare the (AS) with the standard rigid socket (RS) in 25 adults with transtibial amputation. Participants will wear each socket for approximately 4 weeks (after a 1-2 week adaptation period) in a randomized order. The primary outcome is the Patient Specific Functional Scale (PSFS). Secondary outcomes include comfort (SCS), satisfaction (OPUS), psychosocial adjustment (TAPES-R), mobility (PLUS-M), prosthesis utility (PEQ-U), and the proportion of patients electing to keep the AS at study completion.

Studie Overzicht

Gedetailleerde beschrijving

Background. Lower-limb amputation affects more than 7,500 people annually in France, with approximately 50% at the transtibial level. The socket is the critical interface between the residual limb and the prosthesis, transmitting mechanical forces while needing to remain comfortable. Currently, only RS (carbon or resin) are listed on the French reimbursable products list (LPPR) for transtibial amputation. Documented limitations of rigid sockets include restricted knee flexion, walking discomfort in challenging environments, donning difficulties, and suboptimal pressure distribution that does not adapt to residual-limb volume changes.

Investigational device. The AS follows the same molding and shaping principles as the standard RS but differs in two manufacturing steps: (1) carbon fibers are placed only on lateral, postero-inferior, and inferior areas to provide structural rigidity; (2) stratification uses urethane resin (ProtheFLEX®, already used in medical-device manufacturing) instead of epoxy or acrylic resin, creating soft zones in regions typically rigid in conventional sockets.

Comparator. Both sockets are manufactured from the same plaster mold to ensure strictly identical internal geometry. Only the material structure (carbon/urethane distribution) differs; all other prosthetic components (intermediate piece, prosthetic foot) are identical.

Design rationale. A double-blind design is not feasible because participants can perceive differences in socket rigidity and prosthesis weight. The crossover design controls for between-subject variability and order effects.

Sample size. Based on the preliminary study (Patient Specific Functional Scale (PSFS) standard deviation 1.74), to detect a difference of 1.3 points (the PSFS MDC₉₀ for 3 items) with 80% power and α=0.05, 19 participants are required. 25 will be enrolled to account for dropouts and to provide a more representative sample for secondary endpoints.

Visits. Four study visits over approximately 14-21 weeks per participant: inclusion (V0), evaluation after first socket period (V1), evaluation after second socket period (V2), and an optional follow-up visit (V3) one month later if the participant elects to keep the AS.

Studietype

Ingrijpend

Inschrijving (Geschat)

25

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

Studie Locaties

      • Clamart, Frankrijk, 92140
        • Werving
        • Hôpital National d'Instruction des Armées (HNIA) Percy
        • Hoofdonderzoeker:
          • Marie Thomas-Pohl, MD
        • Contact:
      • Freyming-Merlebach, Frankrijk, 57804
        • Werving
        • Hôpital Filieris de Freyming-Merlebach
        • Contact:
        • Hoofdonderzoeker:
          • Catherine Achour
      • Grenoble, Frankrijk, 38434
        • Werving
        • CHU Grenoble Alpes - Hôpital Sud
        • Contact:
        • Hoofdonderzoeker:
          • Solène MAret, MD
        • Onderonderzoeker:
          • Phillipe Escobar, MD
      • Nancy, Frankrijk, 54000
      • Paris, Frankrijk, 75007
        • Werving
        • Insititution Nationale des Invalides
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Unilateral or bilateral transtibial amputation
  • Currently fitted with a definitive carbon rigid socket
  • Any residual-limb shape
  • Any etiology
  • Able to understand simple instructions, read, write, and provide informed consent - or able to be accompanied by a trusted person in case of inability to read/write autonomously
  • Provided free written informed consent
  • Aged 18 years or older
  • Affiliated to a social security system

Exclusion Criteria:

  • Use of hydroalcoholic solution (HAS) for socket donning
  • Currently fitted with a provisional socket
  • Neurological pathology limiting capacity to participate in activities
  • Orthopedic pathology limiting capacity to participate in activities
  • Pregnant or breastfeeding women
  • Minors
  • Persons not under legal protection or unable to express consent
  • Persons under guardianship or curatorship
  • Persons under judicial protection

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Crossover-opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Group 1 (RS -> AS)
Participants wear their standard rigid socket (RS) for 4 weeks, complete evaluation, then switch to the Access Socket (AS) for 1-2 weeks of adaptation followed by 4 weeks of wear, with a second evaluation.
Hybrid prosthetic socket combining a rigid carbon-fiber structure in load-bearing areas (lateral, postero-inferior, inferior) with flexible urethane-resin (ProtheFLEX®) zones in regions typically rigid in conventional sockets. Manufactured from the same plaster mold as the rigid socket to ensure identical internal geometry.
Conventional definitive carbon-fiber rigid socket, currently the only socket type reimbursed in France for transtibial amputation (LPPR-listed). Standard of care comparator.
Actieve vergelijker: Group 2 (AS -> RS)
Participants receive the Access Socket (AS) first, with 1-2 weeks of adaptation followed by 4 weeks of wear and evaluation. They then switch to the standard rigid socket (RS) for 1-2 weeks of adaptation and 4 weeks of wear, with a second evaluation.
Hybrid prosthetic socket combining a rigid carbon-fiber structure in load-bearing areas (lateral, postero-inferior, inferior) with flexible urethane-resin (ProtheFLEX®) zones in regions typically rigid in conventional sockets. Manufactured from the same plaster mold as the rigid socket to ensure identical internal geometry.
Conventional definitive carbon-fiber rigid socket, currently the only socket type reimbursed in France for transtibial amputation (LPPR-listed). Standard of care comparator.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Patient Specific Functional Scale (PSFS) score
Tijdsspanne: One time at the end of each 4-week wear period (V1, V2 and V3)
Patient-centered self-report tool. The patient identifies 3-5 specific activities they have difficulty performing, then rates their ability on a 0-10 scale (0 = unable to perform, 10 = able to perform at pre-injury level). The final score is the mean of the ratings
One time at the end of each 4-week wear period (V1, V2 and V3)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Socket Comfort Scale (SCS) score
Tijdsspanne: One time at the end of each 4-week wear period (V1, V2 and V3)
0-10 numerical rating of socket comfort (0 = least comfortable imaginable, 10 = most comfortable imaginable)
One time at the end of each 4-week wear period (V1, V2 and V3)
Orthotics Prosthetics Users Survey (OPUS) score
Tijdsspanne: One time at the end of each 4-week wear period (V1, V2 and V3)
Self-report instrument evaluating functional outcomes and quality of life specifically for orthosis and prosthesis users. Assesses lower-limb functional status, health-related quality of life, satisfaction with the device, and satisfaction with services. The higher the score, the more favorable the result for the device
One time at the end of each 4-week wear period (V1, V2 and V3)
Trinity Amputation and Prosthesis Experience Scale - Revised (TAPES-R) score
Tijdsspanne: One time at the end of each 4-week wear period (V1, V2 and V3)
33-item multidimensional questionnaire evaluating psychosocial adjustment to amputation and prosthesis use, including general adjustment, social adjustment, activity restriction, and prosthesis satisfaction. The higher the global score, the more favorable the result for the device
One time at the end of each 4-week wear period (V1, V2 and V3)
Prosthesis Evaluation Questionnaire - Utility subscale (PEQ-U) score
Tijdsspanne: One time at the end of each 4-week wear period (V1, V2 and V3)
The score is calculated as the mean of the 8 items in the subscale. Each item is rated on a Visual Analogue Scale (VAS) from 0 to 100. The total score ranges from 0 to 100, where higher scores indicate a better outcome (greater satisfaction and prosthesis utility)
One time at the end of each 4-week wear period (V1, V2 and V3)
Proportion of participants electing to keep the Access Socket at study completion
Tijdsspanne: Through study completion, an average of 10 weeks
Percentage of participants who choose the AS over the RS at the end of the study, reported with 95% confidence interval. Participants are not informed of this option until the end of the study to avoid judgment bias
Through study completion, an average of 10 weeks

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

27 april 2026

Primaire voltooiing (Geschat)

27 april 2027

Studie voltooiing (Geschat)

30 oktober 2027

Studieregistratiedata

Eerst ingediend

5 mei 2026

Eerst ingediend dat voldeed aan de QC-criteria

13 mei 2026

Eerst geplaatst (Werkelijk)

18 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

18 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

13 mei 2026

Laatst geverifieerd

1 mei 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

: Individual participant data will not be shared. Aggregated study results will be published in scientific journals and a summary report will be transmitted to the CPP within 12 months of study completion

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren